Baxter International management check
BAX · Health Care · Health Care Equipment · CEO Andrew P. Hider
Filings as of
Closest peers in Health Care Equipment
- 153ISRGIntuitive Surgical72
- 158ABTAbbott Laboratories72
- 162SYKStryker Corporation71
- 185IDXXIdexx Laboratories69
- 199BSXBoston Scientific68
- 250RVTYRevvity64
- 284RMDResMed63
- 286GEHCGE HealthCare62
- 322STESteris60
- 353BDXBecton Dickinson58
The seven checks
- FlagTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
016thDetail
$100 invested at the start of fiscal 2021 grew to $27, against $148 for the peer group the company picked itself.
- WatchPay only loosely tracked returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
5718thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.15 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- FlagPaid in a loss-making year
What does the CEO cost owners?
$29.8m pay · −$957.0m net income, FY2025
016thDetail
$29.8m of reported pay in fiscal 2025, a year the company lost $957.0m.
- WatchCEO stake ≈ 0.4 years of pay
Do they own the stock?
518,447 shares ≈ $13.3m
6 mo: ▲ $0 bought · ▼ $0 sold
1717thDetail
The CEO holds 518,447 shares, directly or through trusts (unvested awards not counted): about 0.4 years of pay. No open-market insider buying or selling in the last six months.
- WatchShare count growing
Are owners being diluted?
Diluted shares +0.5% a year; flagged above +2%
Stock pay 1.0% of revenue
4425thDetail
Diluted shares changed +0.5% a year over the last three fiscal years. Stock-based pay was 1.0% of revenue in the latest year.
- Flag3 CEOs in the pay table
Is leadership stable?
16 filings under 8-K 5.02 in 3 years
CEOs: Mr. Almeida, Mr. Shafer, Mr. Hider
04thDetail
CEOs in the pay table: Mr. Almeida, Mr. Shafer, Mr. Hider. 16 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed March 23, 2026.
Pay tied most to et Sales From Continuing Operations
Other key measuresNet Sales From Continuing OperationsAdjusted Earnings Per Share From Continuing OperationsFree Cash Flow From Continuing OperationsROICRelative TSR
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Mr. Almeida, Mr. Shafer, Mr. Hider | $29.8m | $14.7m | $5.2m | $27 | $148 | −$957.0m |
| 2024 | — | $18.1m | $9.2m | $6.5m | $40 | $129 | −$638.0m |
| 2023 | — | $13.8m | $10.4m | $5.2m | $51 | $126 | $2.7bn |
| 2022 | — | $13.6m | −$9.1m | $6.7m | $66 | $124 | −$2.4bn |
| 2021 | — | $15.6m | $19.6m | $4.9m | $108 | $126 | $1.3bn |
Insiders and the CEO's stakeQuiet
- President and CEO
- Andrew P. Hider
- Shares held
- 518,447
- At that filing's price
- ≈ $13.3m
- Latest Form 4
- Sep 2, 2026
No open-market insider buying or selling in the last six months.
Open-market trades by officers and directors since May 21, 2026.
Leadership and governance on file
All 25 filings
- Aug 19, 2026Leadership change8-K 5.02
- Aug 4, 2026Leadership change8-K 5.02
- May 8, 2026Leadership change8-K 5.02
- Mar 16, 2026Leadership change8-K 5.02
- Feb 12, 2026Leadership change8-K 5.02
- Nov 12, 2025Leadership change8-K 5.02
- Oct 21, 2025Leadership change8-K 5.02
- Jul 7, 2025Leadership change8-K 5.02
- Feb 3, 2025Leadership change8-K 5.02
- Feb 3, 2025Leadership change8-K 5.02
- Jan 31, 2025Leadership change8-K 5.02
- Nov 22, 2024Leadership change8-K 5.02
- Sep 9, 2024Leadership change8-K 5.02
- Sep 3, 2024Leadership change8-K 5.02
- Aug 13, 2024Leadership change8-K 5.02
- May 9, 2024Leadership change8-K 5.02
- Oct 3, 2023Leadership change8-K 5.02
- Aug 21, 2023Leadership change8-K 5.02
- Jun 29, 2023Leadership change8-K 5.02
- May 9, 2023Leadership change8-K 5.02
- Feb 14, 2023Leadership change8-K 5.02
- Jan 6, 2023Leadership change8-K 5.02
- May 6, 2022Leadership change8-K 5.02
- Dec 13, 2021Leadership change8-K 5.02
- Nov 30, 2021Leadership change8-K 5.02
Latest shareholder vote results: May 8, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $3.3bn returned to owners in buybacks and dividends, and $632.0m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $12.1bn | $10.1bn | $10.4bn | $10.6bn | $11.2bn |
| Net income | $1.3bn | −$2.4bn | $2.7bn | −$649.0m | −$957.0m |
| Stock-based pay | $146.0m | $140.0m | $115.0m | $114.0m | $117.0m |
| Buybacks | $600.0m | $32.0m | $0 | $0 | — |
| Dividends | $530.0m | $573.0m | $586.0m | $590.0m | $348.0m |
| Diluted shares | 508m | 504m | 508m | 510m | 513m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.